secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001824293-24-000143
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio raises $13.9M in gross proceeds since Jan 2024; cash runway into mid Q1 2025
--------------------------------------------------------------------------------

- Closed Oct 22 warrant exercise for 762,236 shares raising $0.8M gross proceeds.
- Total gross proceeds since start of 2024 are approximately $13.9M.
- Cash runway estimated into mid Q1 2025, supporting Phase 2a interim data for GRI-0621 (IPF).
- Issued new Series D-1 and D-2 warrants with exercise price of $1.00 per share.
- H.C. Wainwright acted as exclusive placement agent for the offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000143/0001824293-24-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000143/val-20241024.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer